Pancreatic Cancer Research

ResearcherUniversity of CopenhagenActive in the last 2 years

Stefan Kobbelgaard Burgdorf

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2844-2129; OpenAlex author ID A5035065864. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 4 papers · 2026: 3 papers

Papers 12

  1. The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Co-author DOI 10.1002/gin2.70074↗
  2. Response to 'Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer'. Co-author DOI 10.1038/s41416-025-03294-w↗
  3. Distal and Total Pancreatectomy With En Bloc Celiac Axis Resection for Pancreatic Cancer at a High-Volume Center. First author DOI 10.1097/as9.0000000000000688↗
  4. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. Co-author DOI 10.1001/jamaoncol.2024.5917↗
  5. Redirecting venous flow from the superior mesenteric vein to the inferior mesenteric vein in resections for locally advanced pancreatic cancer. Co-author DOI 10.1007/s00423-025-03818-1↗
  6. Association of chemotherapy completion rates and overall survival with postoperative complications after pancreaticoduodenectomy for pancreatic ductal adenocar… Co-author DOI 10.1016/j.hpb.2024.11.002↗
  7. Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an interna… Co-author DOI 10.1038/s41416-025-03025-1↗
  8. Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy. Co-author DOI 10.1001/jamanetworkopen.2024.17625↗
  9. Have a vital end-user been overlooked? Developing a shared decision intervention for patients with potential pancreatic cancer regarding the choice of surgery. Co-author DOI 10.1016/j.pecinn.2024.100269↗
  10. Perioperative factors associated with survival following surgery for pancreatic cancer - a nationwide analysis of 473 cases from Denmark. Co-author DOI 10.1186/s12893-024-02369-4↗
  11. Impact of para aortic lymph node removal on survival following resection for pancreatic adenocarcinoma. Co-author DOI 10.1186/s12893-023-02123-2↗
  12. Long-Term Outcomes of Venous Resections in Pancreatic Ductal Adenocarcinoma Patients: A Nationwide Cohort Study. Co-author DOI 10.1097/as9.0000000000000219↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jan Henrik Storkholm · 6 shared papers, 2022–2026 · strength 1.69
  2. Carsten Palnæs Hansen · 6 shared papers, 2022–2026 · strength 1.51
  3. Martin Sillesen · 5 shared papers, 2022–2025 · strength 1.01
  4. Sophie Louise Gisela Kollbeck · 3 shared papers, 2023–2025 · strength 0.66
  5. Jens Hillingsø · 2 shared papers, 2024–2025 · strength 0.44
  6. Nagy Adley Habib · 1 shared paper, 2025 · strength 0.37
  7. Mogens Tornby Stender · 2 shared papers, 2022–2023 · strength 0.36
  8. Laura Marr Spore · 1 shared paper, 2024 · strength 0.22
  9. Kristine Elberg Dengsø · 1 shared paper, 2024 · strength 0.19
  10. Claus Wilki Fristrup · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.